Loading...
•
Sep 30, 2023
AMN Healthcare Q3 2023 Earnings Report
AMN Healthcare announced Q3 2023 results with revenue of $853 million, GAAP EPS of $1.39, and adjusted EPS of $1.97.
Key Takeaways
AMN Healthcare's Q3 2023 revenue was $853.5 million, a 25% decrease year-over-year. Net income was $53 million, or $1.39 per diluted share, compared to $92 million, or $2.10 per diluted share, in Q3 2022. Adjusted diluted EPS was $1.97 compared to $2.57 in the same quarter last year.
Consolidated revenue for the quarter was $853.5 million, a 25% decrease from prior year.
Net income was $53 million (6.2% of revenue), or $1.39 per diluted share.
Adjusted diluted EPS in the third quarter was $1.97 compared with $2.57 in the same quarter a year ago.
In October 2023, AMN signed a definitive agreement to acquire MSDR for approximately $300 million.
Revenue by Segment
Forward Guidance
Revenue in the fourth quarter of 2023 is expected to be 28-30% lower than prior year and 5-7% lower sequentially. Guidance does not include any contribution from the MSDR acquisition, which we expect to close later in the fourth quarter.
Challenges Ahead
- Nurse and Allied Solutions segment revenue is expected to be down 33-35% year over year.
- Physician and Leadership Solutions segment revenue is expected to be down 12-14% year over year.
- For the Technology and Workforce Solutions segment, we expect revenue to be approximately 18% lower year over year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...